AbstractDespite the advancement in blood pressure (BP) lowering medications, uncontrolled hypertension persists, underscoring a stagnation of effective clinical strategies. Novel and effective lifestyle therapies are needed to prevent and manage hypertension to mitigate future progression to cardiovascular and chronic kidney diseases. Chrono‐nutrition, aligning the timing of eating with environmental cues and internal biological clocks, has emerged as a potential strategy to improve BP in high‐risk populations. The aim of this review is to provide an overview of the circadian physiology of BP with an emphasis on renal and vascular circadian biology. The potential of Chrono‐nutrition as a lifestyle intervention for hypertension is discussed and current evidence for the efficacy of time‐restricted eating is presented.

More from our Archive

• DOI: 10.1111/andr.13581 2024

  Sex hormones and the total testosterone:estradiol ratio as predictors of severe acute respiratory syndrome coronavirus 2 infection in hospitalized men

  David Ruiz‐Ochoa, Armando‐Raúl Guerra‐Ruiz, María‐Teresa García‐Unzueta, Pedro Muñoz‐Cacho, Bryan Rodriguez‐Montalvan, Carlos Antonio Amado‐Diago, Bernardo‐Alio Lavín‐Gómez, María‐Eliecer Cano‐García, Daniel Pablo‐Marcos, Luis Alberto Vázquez

• DOI: 10.1111/dme.15278 2024

  Preterm delivery and maternal obesity remain common complications in pregnancies with type 1 diabetes—A nationwide study in Sweden

  Sven Sandin, Hans Järnbert‐Pettersson, Martina Persson

• DOI: 10.1155/2024/5287580 2024

  Association of Monocyte-to-HDL Cholesterol Ratio with Endothelial Dysfunction in Patients with Type 2 Diabetes

  Huihui Zhang, Jun Lu, Jie Gao, Wenjun Sha, Xinhua Cai, Mai Re Yan Mu Rouzi, Yuanying Xu, Wenjun Tang, Tao Lei

• DOI: 10.1111/dom.15439 2024

  First‐in‐human study of <scp>CPL207280</scp>, a novel G‐protein‐coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration

  Katarzyna Bazydło‐Guzenda, Katarzyna Jarus‐Dziedzic, Agnieszka Gierczak‐Pachulska, Paweł Buda, Piotr J. Rudzki, Katarzyna Buś‐Kwaśnik, Ewelina Juszczyk, Ewa Tratkiewicz, Daniel Rabczenko, Agnieszka Segiet‐Święcicka, Maciej Wieczorek

• DOI: 10.1111/dom.15428 2024

  Validation of an international classification of disease, tenth revision, clinical modification (<scp>ICD‐10‐CM</scp>) algorithm in identifying severe hypoglycaemia events for real‐world studies

  Qoua L. Her, Sara Z. Dejene, Sherin Ismail, Tiansheng Wang, Michele Jonsson‐Funk, Virigina Pate, Jea Young Min, James Flory

• DOI: 10.1111/dom.15412 2024

  Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the <scp>ORIGIN</scp> trial

  Tali Cukierman‐Yaffe, Chinthanie Ramasundarahettige, Jackie Bosch, Hertzel C. Gerstein

• DOI: 10.2174/0115733998263359231211044539 2024

  Comparing Methods for Induction of Insulin Resistance in Mouse 3T3-L1 Cells

  Hend Al-Jaber, Shamma Al-Muraikhy, Aldana Jabr Jabr, Aisha Yousuf, Najeha Anwardeen, Mohamed Elrayess, Layla Al-Mansoori

• DOI: 10.1002/oby.23953 2024

  Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass

  Navin Suthahar, Victor Zwartkruis, Bastiaan Geelhoed, Coenraad Withaar, Laura M. G. Meems, Stephan J. L. Bakker, Ron T. Gansevoort, Dirk Jan van Veldhuisen, Michiel Rienstra, Rudolf A. de Boer

• DOI: 10.1111/jne.13365 2024

  Early corticosterone increases vocal complexity in a wild parrot: An organizational role of the hypothalamic–pituitary–adrenal axis in vocal learning?

  Celia R. McLean, Astolfo Mata, Richard J. Kline, Karl S. Berg

• DOI: 10.1210/clinem/dgae015 2024

  Insulin resistance and CGM-derived parameters in people with type 1 diabetes: are they associated?

  Isabel Clinck, Jonathan Mertens, Kristien Wouters, Eveline Dirinck, Christophe De Block